Bottom line
What is VPVFHIV's expense ratio?
VPVFHIV's expense ratio is 1.09%, or about $109 a year on every $10,000 invested. That is more expensive than 69% of global bond funds we track (median 0.89%). Its expense ratio includes a 0.15% 12b-1 marketing fee.
Updated Apr 28, 2026
VPVFHIV fee table
| Net expense ratio | 1.09% |
|---|---|
| Gross expense ratio | 1.09% |
| Management fee | 0.75% |
| 12b-1 (distribution) fee | 0.15% |
| Other expenses | 0.19% |
| Max front-end sales load | None (ETF) |
Source: Fund prospectus fee table, filed Apr 28, 2026
What VPVFHIV costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| VPVFHIV | $111 | $347 | $601 | $1,329 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.09% expense ratio costs roughly $59,900 in lost growth, versus about $49,800 for the median global bond fund (0.89%).